Navigating the Optimal Threshold of Examined Lymph Nodes for Pathological T2-4 Gastric Cancer in China: A Multi-Center, Hospital-Based Study Covering 20 Years of Data
Lulu Zhao,Fan Zhang,Fuzhi Jiao,Xiadong Zhou,Penghui Niu,Xue Han,Wanqing Wang,Xiaoyi Luan,Mingyan He,Quanlin Guan,Yu-min Li,Dongbing Zhao,Yingtai Chen
DOI: https://doi.org/10.2139/ssrn.4276605
2022-01-01
Abstract:Introduction: The current National Comprehensive Cancer Network (NCCN) guidelines recommend that a minimum of 16 lymph nodes should be examined for gastric cancer patients in order to reducing staging migration, however, debate remains regarding the optimal management of examined lymph nodes (ELNs) for gastric cancer patients so far. We aimed to develop and test the optimal threshold of ELNs that should be retrieved during gastrectomy for gastric cancer.Methods: We used the restricted cubic spline (RCS) to identify the optimal threshold of ELNs that should be retrieved during gastrectomy based on the China National Cancer Center Gastric Cancer (NCCGC) database. Northwest cohort, which sourced from the highest gastric cancer incidence areas in China, was used to verify the optimal cutoff value. Survival analysis was performed via Kaplan-Meier estimates and Cox proportional hazards models.Results: In this study, 12670 gastrectomy patients were included in the NCCGC cohort and 4941 patients in the Northwest cohort. During 1999-2019, the average number of ELNs increased from 17.88 to 34.45 in the NCCGC cohort, while the number of positive lymph nodes remained stable (5%-6%). The RCS model showed a U-curved association between ELNs and the risk of all-cause mortality, and the optimal threshold of ELNs was 24 [Hazard ratio (HR)=1.00]. The ELN≥24 group had a better overall survival (OS) than the ELN<24 group clearly (P=0.003), however, with respect to the threshold of 16 ELNs, there was no significantly difference between the two groups (P=0.101). In the multivariate analysis, ELN≥24 group was associated with improved survival outcomes in total gastrectomy patients [HR=0.787, 95% confidence interval (CI): 0.711-0.870, P<0.001], as well as the subgroup analysis of T2 patients (HR=0.621, 95%CI: 0.399-0.966, P=0.035), T3 patients (HR=0.787, 95%CI: 0.659-0.940, P=0.008) and T4 patients (HR=0.775, 95%CI: 0.675-0.888, P<0.001).Conclusion: In conclusion, ELN≥24 maintained excellent prognostic value in pathological T2-4 gastric cancer patients and is expected to be the optimal threshold for ELNs. In addition, the ELNs number of 16 was not a universal cutoff value for gastrectomy patients, mainly because there was no statistical difference between ELN<16 and ELN≥16 groups for patients with pathological T2 in multivariate analysis. Future study with larger sample size is required to confirm these findings of the present study.Funding Information: This work was supported by the grant from National Key R&D Program of China (No. 2017YFC0908300) and Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2021-RC310-009).Declaration of Interests: The authors declare no conflicts of interest.Ethics Approval Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was approved by the ethics committee of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. 17- 156/1412).